↓ Skip to main content

Cancer Prevention II

Overview of attention for book
Cover of 'Cancer Prevention II'

Table of Contents

  1. Altmetric Badge
    Book Overview
  2. Altmetric Badge
    Chapter 1 Do We Make Optimal Use of the Potential of Cancer Prevention?
  3. Altmetric Badge
    Chapter 2 Predictors of Successful Cancer Prevention Programs
  4. Altmetric Badge
    Chapter 3 Cancer Prevenpinon in the Developing World: Mission Impossible?
  5. Altmetric Badge
    Chapter 4 Is Cancer Prevention Ever Going to Be Profitable?
  6. Altmetric Badge
    Chapter 5 Energy Metabolism, Cancer Risk, and Cancer Prevention
  7. Altmetric Badge
    Chapter 6 Promises and Limitations of Biomarkers
  8. Altmetric Badge
    Chapter 7 The EPIC study: an update.
  9. Altmetric Badge
    Chapter 8 Anti-angiogenic properties of Chemopreventive Drugs: Fenretinide as a Prototype.
  10. Altmetric Badge
    Chapter 9 Retinoids and Breast Cancer Prevention
  11. Altmetric Badge
    Chapter 10 Cancer prevention by vaccination against hepatitis B.
  12. Altmetric Badge
    Chapter 11 Energy Restriction for Breast Cancer Prevention
  13. Altmetric Badge
    Chapter 12 The use of tamoxifen and raloxifene for the prevention of breast cancer.
  14. Altmetric Badge
    Chapter 13 Prevention of ER-negative breast cancer.
  15. Altmetric Badge
    Chapter 14 Exogenous and endogenous hormones, mammographic density and breast cancer risk: can mammographic density be considered an intermediate marker of risk?
  16. Altmetric Badge
    Chapter 15 Chemoprevention of oesophageal cancer and the AspECT trial.
  17. Altmetric Badge
    Chapter 16 Review of Diagnostic Markers for Prostate Cancer 16
  18. Altmetric Badge
    Chapter 17 Seleneium and Vitamin E Cancer Prevention Trial: A Nutrient Approach to Prostate Cancer Prevention
  19. Altmetric Badge
    Chapter 18 Prostate Cancer Prevention by Short-Term Anti-androgens: The Rationale Behind Design of Pilot Studies
  20. Altmetric Badge
    Chapter 19 Anti-angiogenic Activity of a Novel Class of Chemopreventive Compounds: Oleanic Acid Terpenoids
  21. Altmetric Badge
    Chapter 20 Pharmacologic Effects of NSAIDs and Implications for the Risks and Benefits of Long-Term Prophylactic Use of Aspirin to Prevent Cancer
  22. Altmetric Badge
    Chapter 21 Aspirin and NSAIDs for the Prevention of Colorectal Cancer
  23. Altmetric Badge
    Chapter 22 Aspirin and Cancer Risk: A Summary Review to 2007
Attention for Chapter 12: The use of tamoxifen and raloxifene for the prevention of breast cancer.
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Among the highest-scoring outputs from this source (#31 of 172)
  • High Attention Score compared to outputs of the same age (87th percentile)

Mentioned by

blogs
1 blog
wikipedia
2 Wikipedia pages

Citations

dimensions_citation
1 Dimensions

Readers on

mendeley
24 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Chapter title
The use of tamoxifen and raloxifene for the prevention of breast cancer.
Chapter number 12
Book title
Cancer Prevention II
Published in
Recent results in cancer research Fortschritte der Krebsforschung Progrès dans les recherches sur le cancer, January 2009
DOI 10.1007/978-3-540-69297-3_12
Pubmed ID
Book ISBNs
978-3-54-069296-6, 978-3-54-069297-3
Authors

Wickerham DL, Costantino JP, Vogel VG, Cronin WM, Cecchini RS, Ford LG, Wolmark N, D. Lawrence Wickerham, Joseph P. Costantino, Victor G. Vogel, Walter M. Cronin, Reena S. Cecchini, Leslie G. Ford, Norman Wolmark, Wickerham, D. Lawrence, Costantino, Joseph P., Vogel, Victor G., Cronin, Walter M., Cecchini, Reena S., Ford, Leslie G., Wolmark, Norman

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 24 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 1 4%
Unknown 23 96%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 8 33%
Lecturer 2 8%
Student > Postgraduate 2 8%
Student > Ph. D. Student 2 8%
Student > Doctoral Student 1 4%
Other 2 8%
Unknown 7 29%
Readers by discipline Count As %
Pharmacology, Toxicology and Pharmaceutical Science 8 33%
Medicine and Dentistry 3 13%
Agricultural and Biological Sciences 2 8%
Business, Management and Accounting 1 4%
Unspecified 1 4%
Other 2 8%
Unknown 7 29%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 9. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 04 December 2020.
All research outputs
#3,773,005
of 22,992,311 outputs
Outputs from Recent results in cancer research Fortschritte der Krebsforschung Progrès dans les recherches sur le cancer
#31
of 172 outputs
Outputs of similar age
#21,107
of 170,009 outputs
Outputs of similar age from Recent results in cancer research Fortschritte der Krebsforschung Progrès dans les recherches sur le cancer
#2
of 4 outputs
Altmetric has tracked 22,992,311 research outputs across all sources so far. Compared to these this one has done well and is in the 83rd percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 172 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.6. This one has done well, scoring higher than 81% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 170,009 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 87% of its contemporaries.
We're also able to compare this research output to 4 others from the same source and published within six weeks on either side of this one. This one has scored higher than 2 of them.